StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
ALNYBearishAnalyst Target Updateanalyst
Medium materiality5/10

Stifel downgrades Alnylam Pharmaceuticals to Hold

Oct 29, 2026, 2:33 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The rating downgrade is a bearish change in analyst stance, though the accompanying target remains above the cited price and limits conviction.

AI summary

What happened, with direct paths to the underlying reporting

Stifel downgraded ALNY to Hold. The cited price was $177.49 and the price change since the signal was -1.35%.

  • Stifel downgraded ALNY to Hold.
  • The cited price target is $225, above the cited share price of $177.49.

Key facts

  1. 01

    Target: $225

  2. 02

    Posted price: $177.49

  3. 03

    Analyst firm: Stifel Nicolaus

  4. 04

    Analyst: Paul Matteis

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event